Page 4 - Health Sector

Consumer protection: Manufacturer held liable for defective hip implant

The National Consumer Commission exonerated the doctor and the hospital but found DePuy and Johnson & Johnson liable for the defective implant

Bio-Thera, Dr. Reddy's partner for biosimilar expansion in Southeast Asia

With this partnership, they aim to enhance access to affordable treatments for patients suffering from autoimmune diseases

Manpower acquisition, retention biggest challenges for R&D GCCs: Expert

GCCs in life sciences and healthcare have grown across India, with Bengaluru, Hyderabad, and Chennai emerging as key hubs

Centre to expand its TB elimination campaign all over India: JP Nadda

This comes after the government's 100-day intensified TB screening campaign concluded on March 24, which is also World TB Day

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

The company currently operates more than 200 centres across India, both under public-private partnerships (PPP) and company-owned standalone clinics, serving over 20,000 patients annually

Everhope Oncology secured $10 million seed funding for expansion

This is the largest healthcare seed round in the last 24 months

NatHealth urges stronger PPPs to meet India's growing healthcare demands

NatHealth also underscored the potential of digital health to increase efficiency and improve healthcare access

IIT-B startup HaystackAnalytics plans to take genome testing to EU, US

Srivastava says that in the next five years they need to invest another $40-50 million or so to build the business, and there are plans to take the infexn test to the US and Europe as well

Aster DM promoters reduce share pledge to 41% for debt refinancing

"This milestone also reinforces trust among our stakeholders, investors, and partners as we continue to expand our footprint in India," added Moopen

Herbalife faces challenge from homegrown Modiway in weight-loss mkt

To put into perspective, the weight-loss market is big and, according to industry estimates, it hit $25 billion in 2024, and is expected to expand to $55 billion by 2033

Centre to expand internet access to Arogya Mandirs, enhance CMO training

The MSG is the highest policy-making and steering institution under the NHM, providing broad policy direction and governance for the health sector

Health insurance premium growth in slow lane due to tapering demand

Change in accounting norms, sharp decline in premiums from govt. schemes have also weighed on health insurance premium growth

'Around 1% of claims related to mental health in group medical insurance'

Beyond awareness and stigma, structural problems within the insurance market also contribute to the low utilisation of mental health benefits

India on verge of becoming trials hub, says clinical research firm exec

The US-based company plans to boost its headcount in India by more than 2,000 over the next three to five years

Regulatory standards must be stronger for quality medicines: Health secy

State drug regulators should ensure that medicines are sold only through prescriptions so that narcotic drugs are not diverted for trafficking or other illicit uses, Union Health Secretary Punya Salila Srivastav has said. Chairing a meeting with state drug regulators to address illicit use of psychotropic drugs under the Nasha Mukt Bharat Abhiyan and strengthen regulatory capacities of states and UTs on Monday, she said regulatory standards need to be strong to ensure that only quality and effective medicines circulate in the country. During the meeting, Srivastava urged state drug regulators to ensure that medicines are sold only through prescriptions so that narcotic drugs are not diverted for trafficking or other illicit uses. She also complimented Central Drugs Standard Control Organisation (CDSCO) and state drug regulators for completing risk-based inspections of 905 drug manufacturing and testing firms, resulting in 694 actions being taken so far. The meeting comes in the wa

Health Secy asks state bodies to curb illicit use of psychotropic drugs

While Tapentadol is a strong opioid used to relieve severe pain, Carisoprodol is a muscle relaxant for painful bone conditions

Govt asks IVD kit makers to report adverse events; aims to collate info

Releases draft format for adverse events for rapid identification and rectification of potential device failures

Upside ahead for Apollo Hospitals on robust guidance, valuations

APHS delivered strong growth in realisation per patient as well as number of patients

ePlane, ICATT ink deal for 788 air ambulances valued at over $1 billion

ICATT, which provides a world-class air ambulance service in India, will procure 788 air ambulances from ePlane, ensuring rapid medical intervention across all districts in the country

Fortis Healthcare to acquire 228 bed hospital in Punjab for Rs 462 crore

Move aims to strengthen chain's Punjab cluster with over 1,000 beds